Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 1998;83:133-140

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hanawa, H.
Right arrow Articles by Aizawa, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hanawa, H.
Right arrow Articles by Aizawa, Y.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Autoimmune Diseases
*Cardiomyopathy
(Circulation Research. 1998;83:133-140.)
© 1998 American Heart Association, Inc.


Original Contributions

T Cells With Similar T-Cell Receptor ß-Chain Complementarity-Determining Region 3 Motifs Infiltrate Inflammatory Lesions of Synthetic Peptides Inducing Rat Autoimmune Myocarditis

Haruo Hanawa, Takayuki Inomata, Yuji Okura, Satoru Hirono, Yusuke Ogawa, Tohru Izumi, Makoto Kodama, , Yoshifusa Aizawa

From the First Department of Internal Medicine (H.H., T. Inomata, Y.O., S.H., Y.O., M.K., Y.A.), Niigata University School of Medicine, Niigata, Japan, and the Department of Internal Medicine (T. Izumi), Kitasato University School of Medicine, Sagamihara, Japan.

Correspondence to Haruo Hanawa, MD, First Department of Internal Medicine, Niigata University School of Medicine, Asahi-machi 1-754, Niigata 951, Japan.


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowMaterials and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Abstract—Experimental autoimmune myocarditis (EAM) resembles the giant cell myocarditis seen in humans, and recurrent forms lead to dilated cardiomyopathy. EAM has been shown to be a T cell–mediated autoimmune myocarditis. We have previously shown that cDNA encoding Vß complementarity-determining region (CDR) 3 from heart– and pericardial space–infiltrating T cells in EAM induced by rod cardiac myosin contains more restricted sequences than that from normal spleen T cells. Recently, it has become apparent that several epitopes of EAM exist in rod cardiac myosin; therefore, T cells infiltrating into lesions may recognize certain epitopes in EAM induced by rod cardiac myosin. In this study, we examined heart– and pericardial space–infiltrating T-cell clonotypes in EAM induced by synthetic peptides of cardiac myosin. EAM was produced by immunization with synthetic peptides corresponding to N-terminally acetylated amino acids 1539 to 1555 of rat cardiac myosin {alpha} heavy chain. Five of 12 rats receiving synthetic peptides developed macroscopic signs of myocarditis. To examine T-cell receptor (TCR) Vß expression and CDR3 of the TCR ß chain of lesion-infiltrating T cells in EAM, total RNA was isolated from heart, pericardial effusion, spleen, lymph node, and peripheral blood. TCR Vß expression of the T cells infiltrating the lesions revealed a predominance of Vß4. On the basis of single-strand conformation polymorphism analysis for CDR3 of the TCR Vß4 chain, heart– and pericardial space–infiltrating T cells were considered to be oligoclonal, whereas spleen, lymph node, and peripheral blood in a rat with EAM and spleen in a native rat were considered to be polyclonal. In the same rat, clonotypes of heart-infiltrating T cells were almost the same as those of pericardial space–infiltrating T cells. Furthermore, on sequence analysis for CDR3 of the TCR Vß4 chain, the amino acid motifs were similar among T cells infiltrating into lesions of different EAM rats. In the present study, TCR ß chains of heart– and pericardial space–infiltrating T cells in EAM induced by synthesized peptide consisting of 17 amino acids were examined. Vß4+ T cells with similar Vß CDR3 motifs that infiltrate the heart and pericardial space may recognize the same epitope.


Key Words: myocarditis • T-cell receptor • epitope • cardiomyopathy • immune system


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowMaterials and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
EAM induced by injecting cardiac myosin into susceptible strains of rats and mice resembles the giant cell myocarditis seen in humans, and the recurrent forms lead to dilated cardiomyopathy.1 2 3 EAM in rats is characterized by cardiomegaly, pericardial effusion, and extensive myocardial necrosis. Mononuclear cells, which are almost exclusively macrophages and CD4+ T cells, massively infiltrate the heart and pericardial space.4 5 EAM has been shown to be a T cell–mediated autoimmune disease by adoptive transfer, and the prevention of EAM by anti-{alpha}ßTCR antibody indicates the important role of {alpha}ßT cells.6 7 8

{alpha}ßT cells recognize antigenic peptides in the context of major histocompatibility as a result of interaction of the peptide major histocompatibility complex with the {alpha} and ß chains.9 In the TCR {alpha} chain, CDR3 contacts the NH2-terminal portion of the peptide, whereas the TCR ß chain contacts the COOH-terminal portion of the peptide.10

A previous study has shown oligoclonal expansion of T cells in lesions from rats with EAM induced by rod cardiac myosin.11 These oligoclonal T cells may recognize specific antigens, release cytokines to initiate myocarditis, and activate macrophages that release NO to injure myocytes.12 13 More recently, it has become apparent that there are several epitopes of EAM in rod cardiac myosin.14 15 16 17 18 We indicated that the myocardiogenic epitopes in Lewis rats were located in the RDCB9 (residues 1070 to 1165) of the rod cardiac myosin and that a cryptic minor epitope may reside in S-1.17 On the other hand, a study by Wegmann et al18 demonstrated that epitopes in Lewis rat EAM were located in the CM1 (residues 1304 to 1320) and CM2 (residues 1539 to 1555) of the cardiac myosin.18 To identify CM peptides with myocarditogenic properties, Wegmann et al made use of a putative binding motif for the major histocompatibility class II molecule RT1.B1 in the rat. Because there are several epitopes of EAM in rod cardiac myosin, T cells in lesions from rats with EAM induced by rod cardiac myosin may recognize certain antigenic peptides. Such T cells may constitute groups that recognize different antigenic peptides. In the present study, we elucidate T-cell clonality in inflammatory lesions from rats with EAM induced by synthetic peptide CM2, which may be a single epitope.


*    Materials and Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Materials and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Animals
Lewis rats were obtained from Charles River, Japan (Atsugi, Kanagawa, Japan) and were maintained in our animal facilities until they reached 6 weeks of age.

Induction of EAM
N-terminal acetylated synthetic peptides corresponding to aa 1539 to 1555 (CM2) of rat cardiac myosin {alpha} heavy chain were constructed and purified by Sawady Technology Co. CM2 peptides were dissolved in PBS at a concentration of 4 mg/mL and emulsified with an equal volume of complete Freund's adjuvant supplemented with 10 mg/mL of Mycobacterium tuberculosis H37RA (Difco). To produce actively induced EAM, on day 0, rats received a single immunization at 4 subcutaneous sites on the foot with a total of 0.4 mL of emulsion for each rat, thus yielding an immunizing dose of 800 µg of CM peptide per rat.

RT-PCR Analysis of Vß Expression
Lymph nodes and spleen mononuclear cells were isolated by forcing popliteal lymph node and spleen through a 200-gauge stainless steel mesh. Red blood cells in the spleen cell preparation were lysed in 0.17 mol/L Tris supplemented with 0.83% NH4Cl. Mononuclear cells in peripheral blood were isolated by Ficoll-Paque (Pharmacia) density gradient centrifugation at 1000g for 20 minutes. Mononuclear cells in pericardial effusion were isolated after hemolysis in 0.17 mol/L Tris supplemented with 0.83% NH4Cl. Total RNA was isolated from heart, lymph node, spleen, peripheral blood, and pericardial effusion by acid guanidinium thiocyanate–phenol–chloroform extraction. cDNA was synthesized from 10 µg of total RNA with a TCR Cß primer and murine Moloney leukemia virus reverse transcriptase (GIBCO-BRL) in a final volume of 20 µL. Vß-specific PCR products were generated with AmpliTaq polymerase (Toyobo Co), 22 Vß-specific primers,19 and the same Cß primer from 1 µL of heart cDNA and 0.2 µL of lymph node, spleen, peripheral blood, and pericardial effusion cDNA, according to the following amplification profile: 30 cycles at 94°C for 60 seconds, 55°C for 90 seconds, and 72°C for 120 seconds. Amplified products were separated on 3% agarose gels and stained with ethidium bromide.

PCR Single-Strand Conformation Polymorphism
Amplified PCR products were diluted (2:3) in denaturing solution (95% formamide, 10 mmol/L EDTA, 0.1% bromophenol blue, and 0.1% xylene cyanol), heated at 96°C for 5 minutes, and then cooled on ice for 10 minutes. The diluted sample (10 µL) was adjusted to 50% glycerol, and 3 µL was subjected to single-strand conformation polymorphism by electrophoresis on nondenaturing 5% polyacrylamide (ratio of acrylamide to bisacrylamide, 19:1) gel (14x14x0.1 cm) in 0.5x Tris-borate-EDTA containing 10% glycerol at 14 V/cm for 5 hours at room temperature. DNA fragments were detected with a silver staining kit (Daiichi Chemical Co Ltd).20

Sequencing Analysis
For the purposes of cloning and sequencing, Vß-specific PCR products were purified with microcon-100 (Amicon Inc) and directly inserted into the pGEM-T vector (Promega). The recombinant plasmids were then used to transform Escherichia coli JM109 competent cells (Takara). Individual ampicillin-resistant colonies were isolated, and the plasmid DNA was sequenced with a TaqDye Deoxy terminator cycle sequencing kit and a DNA sequencer (model 373A or 310, Applied Biosystems).


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMaterials and Methods
*Results
down arrowDiscussion
down arrowReferences
 
Induction of EAM
Twelve rats injected with CM2 peptide were killed on day 14 (3 rats), day 17 (5 rats), day 20 (2 rats), and day 23 (2 rats). The 3 rats killed on day 14 did not have macroscopic signs of myocarditis. However, 3 of the 5 rats (Nos. 1, 2, and 3) killed on day 17, 1 of the 2 rats killed on day 20, and 1 of the 2 rats killed on day 23 had developed small macroscopic signs of myocarditis. Four of the rats with myocarditis, except for the rat killed on day 20, had massive pericardial effusion.

RT-PCR Analysis of TCR Vß Expression
We compared TCR Vß expression in the heart and pericardial effusion of the 3 rats with myocarditis on day 17 (early stage) and the rat with myocarditis on day 20 with that of mononuclear cells from normal rat spleen, because a marked bias toward the expression of Vß8.2 was apparent early during the onset of experimental autoimmune encephalomyelitis induced by guinea pig myelin basic protein in Lewis rats.21 22 RNA was extracted from spotty macroscopic white lesions in the hearts of EAM rats. PCR analysis revealed that the expression of Vß4 genes in the hearts and pericardial spaces of EAM rats was more apparent than the expression in normal rat spleen (Figure 1Down).



View larger version (70K):
[in this window]
[in a new window]
 
Figure 1. RT-PCR analysis of TCR Vß gene expression in the spleen of a native Lewis rat (A), the heart (B) and pericardial effusion (C) of 3 EAM rats on day 17, and the heart of an EAM rat on day 20 (D). The ethidium bromide–stained agarose gels of the RT-PCR products are shown. No TCR signal was detected from identical analyses performed on native rat heart, and RT-PCR analysis of TCR Vß gene expression in the heart and pericardial effusion of the other EAM rats on day 17 revealed a predominance of Vß4 (data not shown). Lanes on the left contain ØX174 digested with HaeIII.

PCR Single-Strand Conformation Polymorphism Analysis of TCR Vß4 Chain CDR3
The structure of PCR products corresponding to the CDR3 region of the TCRß chain was examined by single-strand conformation polymorphism analysis. Heterogeneous PCR products corresponding to this region migrate as a smear on single-strand conformation polymorphism analysis, whereas homogeneous products migrate as bands.23 Because Vß4 genes were the dominant genes expressed in the hearts and pericardial spaces of EAM rats, we examined TCR Vß4 chain CDR3. PCR products of TCR Vß4 chain from normal spleen and from individual EAM heart and pericardial effusion on day 17, 20, or 23 migrated as a single band on ethidium bromide–stained agarose gels (Figure 1Up and data not shown). However, on single-strand conformation polymorphism analysis, PCR products from normal spleen produced a smear, whereas those from EAM heart and pericardial effusion generated bands within a smear (Figure 2Down). This shows that oligoclonal T cells expanded in inflammatory lesions in the heart and pericardial effusion but not in normal spleen. Furthermore, the fact that the PCR products from heart and pericardial effusion in the same EAM rat generated the same bands indicates that the clonality of T cells was the same in the heart and pericardial effusion.



View larger version (69K):
[in this window]
[in a new window]
 
Figure 2. Clonal analysis of TCR Vß4 transcripts from the spleen of a native rat (A), the heart (B) and pericardial effusion (C) of an EAM rat on day 17, the heart of an EAM rat on day 20 (D), and the heart (E) and pericardial effusion (F) of an EAM rat on day 23. Silver-stained nondenaturing polyacrylamide gels of PCR products are shown. The arrows indicate bands in smear. No TCR signal was detected from identical analyses performed on native rat heart (data not shown).

We examined the TCR Vß4 chain CDR3 region from popliteal lymph node, spleen, and peripheral blood of EAM rats by single-strand conformation polymorphism analysis (Figure 3Down). It was demonstrated that the cells were polyclonal, unlike the T cells from the heart and pericardial effusion. It demonstrated that oligoclonal T cells expanded only in inflammatory lesions, such as those found in the heart and pericardial effusion.



View larger version (102K):
[in this window]
[in a new window]
 
Figure 3. Clonal analysis of TCR Vß4 transcripts from the spleen (A) and lymph node (B) of an EAM rat on day 17, the spleen of another EAM rat on day 17 (C), and the peripheral blood of an EAM rat on day 23 (D). Top, Silver-stained nondenaturing polyacrylamide gels of PCR products are shown. Bottom, The ethidium bromide–stained agarose gels of the RT-PCR products are shown. No TCR signal was detected from identical analyses performed on native rat heart (data not shown). Lanes on the left contain ØX174 digested with HaeIII.

Sequence Analysis of TCR Vß4 Chain CDR3
CDR3 sequences of Vß4 c DNA from normal spleen revealed no oligoclonal expansion (Figure 4Down). In contrast, their sequences of cDNA from 3 EAM hearts or pericardial effusions on day 17 (Figure 5Down), an EAM heart on day 20 (Figure 6Down), and an EAM heart or pericardial effusion on day 23 (Figure 7Down) revealed oligoclonal expansion. In individual rats, their sequences of Vß4 cDNA from the heart were the same as those from pericardial effusion. To sum up, single-strand conformation polymorphism and sequence analysis indicated that the same clones expanded in the heart and pericardial space. Although these analyses in popliteal lymph node, spleen, and peripheral blood of EAM rats showed polyclonality, some cDNA clones were the same as those of inflammatory lesions of identical EAM rats (Figure 8Down). On the other hand, CDR3 sequences of Vß4 cDNA from the hearts and pericardial spaces of different EAM rats were similar. Seven amino acids of the Vß side of CDR3 were compared with each of the cDNA clones, and cDNA clones differing in <2 amino acid motifs were detected (Figures 5Down, 6Down, and 7Down). No such cDNA clones were found in normal spleen (Figure 4Down).



View larger version (36K):
[in this window]
[in a new window]
 
Figure 4. Vß4 sequences from mononuclear cells isolated from the spleen of a native Lewis rat. Underlined nucleotides indicate variations from the reported Lewis Vß and Jß sequences and may be attributable to polymerase error.51



View larger version (54K):
[in this window]
[in a new window]
 
Figure 5. Vß4 sequences from the hearts and pericardial effusions of 3 EAM Lewis rats on day 17. Vß4 sequences from the heart (A) and pericardial effusion (B) of No. 1 EAM, from the heart (C) and pericardial effusion (D) of No. 2 EAM, and from the heart (E) and pericardial effusion (F) of No. 3 EAM. Letters indicate the cDNA clones that have identical sequences. Numbers on the right indicate cDNA clones that have similar amino acid CDR3 motifs. Seven amino acids of the Vß side of CDR3 were compared with each of the cDNA clones, and cDNA clones differing in <=2 amino acid motifs were regarded as having similar amino acid motifs. Seven amino acids surrounded by squares with the same mark are similar. Underlined nucleotides indicate variations from the reported Lewis Vß and Jß sequences and may be attributable to polymerase error.51 N indicates N region; D, D region.



View larger version (20K):
[in this window]
[in a new window]
 
Figure 6. Vß4 sequences from the heart of an EAM Lewis rat on day 20. Letters, numbers, and squares are as for Figure 5Up. N indicates N region; D, D region.



View larger version (37K):
[in this window]
[in a new window]
 
Figure 7. Vß4 sequences from the heart (A) and pericardial effusions (B) of an EAM Lewis rat on day 23. Letters, numbers, and squares are as for Figure 5Up. N indicates N region; D, D region.



View larger version (57K):
[in this window]
[in a new window]
 
Figure 8. Vß4 sequences from spleen (A) and popliteal lymph node (B) of No. 2 EAM on day 17, from the spleen of No. 3 EAM on day 17 (C), and peripheral blood of EAM on day 20 (D). Letters, numbers, and squares are as for Figure 5Up. Underlined nucleotides indicate variations from the reported Lewis Vß sequences and may be attributable to polymerase error.51 N indicates N region; D, D region.


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMaterials and Methods
up arrowResults
*Discussion
down arrowReferences
 
We examined heart– and pericardial space–infiltrating T-cell clonotypes in EAM induced by synthetic peptides of rat cardiac myosin. Vß expression of T cells infiltrating into lesions revealed a predominance of Vß4, and amino acid CDR3 motifs of the TCR Vß4 chain were similar in different EAM rats. Previously,11 we determined the clonotypes of heart– and pericardial space–infiltrating {alpha}ßT cells in EAM induced by porcine rod cardiac myosin, and we also noted that the cDNA encoding Vß CDR3 from inflammatory lesions of EAM contained more restricted sequences than that from normal spleen. However, the expression of the TCR ß chain V gene was not restricted at the site of inflammation, and T cells with similar amino acid motifs of CDR3 did not infiltrate into inflammatory lesions in different EAM rats. The synthetic peptide used as the myocarditogenic antigen in the present study consisted of 17 amino acids, and major histocompatibility class II molecules are considered to bind peptide antigen consisting of 15 to 18 amino acids24 ; thus, this synthetic peptide is suspected to be a single myocarditogenic epitope. We consider that in EAM induced by the single myocarditogenic epitope, T cells do not respond to other epitopes in rod cardiac myosin; therefore, infiltrating T cells have restricted V ß gene usage with similar amino acid motifs of CDR3.

It is interesting that the CDR3 sequences in hearts and pericardial spaces of individual EAM rats were the same; however, those of different EAM rats were not the same, but they were similar. We suppose that not one but several myocarditogenic T cells can respond to this synthetic peptide epitope. Therefore, in one EAM rat a few clones of myocarditogenic T cells may be activated, and in another EAM rat a few other clones of myocarditogenic T cells may be activated. T cell clones that were cultivated by the same antigenic peptide were reported to have different kinds of TCR with similar CDR3,25 and in recent studies, it was reported that contact with TCR and antigenic peptide in the context major histocompatibility was not strict and that a kind of T-cell clone could respond to several antigenic peptides.26 The present study is compatible with those reports.

Why pericardial effusion arises after immunization with a contractile protein such as myosin heavy chain or synthetic cardiac myosin is very interesting. In EAM, epicardial lesions are more severe than endocardial lesions. In a previous study,4 we showed that many inflammatory cells might infiltrate the heart from the pericardial space. Myocarditogenic T cells that are autoreactive to myosin heavy chain or synthetic cardiac myosin may make contact with antigen-presenting cells in the epicardial region, and T-cell proliferation may occur in the pericardial cavity.

Experimental autoimmune encephalomyelitis, which is similar to multiple sclerosis, is induced in susceptible animal strains by immunization with myelin basic protein. In Lewis rats, the recognition of myelin basic protein clones 68 to 88 is carried out by TCR homologous to Vß8.2, and myelin basic protein clones 87 to 99 are Vß6 specific.19 27 Restriction in TCR usage in pathogenic clones provided a rationale for therapies that prevented and reversed experimental autoimmune encephalomyelitis with Vß-specific monoclonal antibodies.29 The CDR3 of TCRß chains expressed by these clones shows similarities in rats with experimental autoimmune encephalomyelitis.24 26 Remarkably, T cells with the amino acid motif LRG in the CDR3 region are found in lesions produced by experimental autoimmune encephalomyelitis in the Lewis rat after immunization with myelin basic proteins 87 to 99 and in lesions of patients with multiple sclerosis who exhibit HLA DR2.19 30 T cell clones in Lewis rats and in patients with multiple sclerosis, which express this CDR3 motif, all have been reported to have specificity for myelin basic protein 87 to 99.19 30 If this is so, it is conceivable that a common therapy for multiple sclerosis and animal experimental autoimmune encephalomyelitis can be established.

Myocarditis and dilated cardiomyopathy in humans and in animal models has been studied intensively. Several viruses,30 31 32 33 34 especially coxsackievirus, are thought to cause human myocarditis or dilated cardiomyopathy, whereas genetic regulation in the host and the interplay between virus persistence and autoimmunity are speculated to produce the later phases of the disease.35 In the pathogenesis of myocarditis and dilated cardiomyopathy, cellular immune responses are considered to play an important role,36 37 and T cells within inflammatory lesions were reported to use a restricted TCR V region38 39 40 41 or TCR CDR3 region11 ; however, the mechanism of heart-specific T-cell responses is not yet clear.

B- and T-cell epitopes of myocarditis or dilated cardiomyopathy have been reported by other investigators.40 41 42 43 44 45 46 Recently, T-cell epitopes of mouse and rat T-cell–mediated EAM were reported.14 15 16 17 18 If the epitope of animal EAM is also the epitope of human myocarditis or dilated cardiomyopathy (eg, myelin basic protein 87 to 99 of experimental autoimmune encephalomyelitis and multiple sclerosis), then the CDR3 of the TCR expressed by T-cell clones should show similarities in EAM and human myocarditis or dilated cardiomyopathy, and it is conceivable that a common therapy for human myocarditis or dilated cardiomyopathy and EAM can be established.

HLA class II (DR and DQ) antigens are suspected to be associated with dilated cardiomyopathy,47 48 and studies of HLA in dilated cardiomyopathy are now being undertaken. Recent immunological studies have characterized the motifs for peptide binding to major histocompatibility classes I and II.49 50 To elucidate the mechanism of myocarditis or dilated cardiomyopathy and establish specific immunotherapies, further studies are needed to clarify the relation between major histocompatibility of patients, pathogenic epitopes, and TCR of pathogenic T cells.


*    Selected Abbreviations and Acronyms
 
CDR = complementarity-determining region
CM peptide = cardiac myosin peptide
EAM = experimental autoimmune myocarditis
HLA = human lymphocyte antigen
PCR = polymerase chain reaction
RT = reverse transcription
TCR = T-cell receptor

Received September 11, 1997; accepted April 27, 1998.


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMaterials and Methods
up arrowResults
up arrowDiscussion
*References
 
1. Kodama M, Matsumoto Y, Fujiwara M, Masani F, Izumi T, Shibata A. A novel experimental model of giant cell myocarditis induced in rats by immunization with cardiac myosin fraction. Clin Immunol Immunopathol. 1990;57:250–262.[Medline] [Order article via Infotrieve]

2. Neu N, Rose NR, Beisel KW, Herskowitz A, Gurri-Glass G, Craig SW. Cardiac myosin induces myocarditis in genetically predisposed mice. J Immunol. 1987;139:3630–3636.[Abstract]

3. Kodama M, Hanawa H, Saeki M, Hosono H, Inomata T, Suzuki K, Shibata A. Rat dilated cardiomyopathy after autoimmune giant cell myocarditis. Circ Res. 1994;75:278–284.[Abstract/Free Full Text]

4. Hanawa H, Tsuchida M, Matsumoto Y, Watanabe H, Abo T, Sekikawa H, Kodama M, Zhang S, Izumi T, Shibata A. Characterization of T cells infiltrating the heart in rats with experimental autoimmune myocarditis: their similarity to extrathymic T cells in mice and the site of proliferation. J Immunol. 1993;150:5682–5695.[Abstract]

5. Kodama M, Zhang S, Hanawa H, Shibata A. Immunohistochemical characterization of infiltrating mononuclear cells in the rat heart with experimental autoimmune giant cell myocarditis. Clin Exp Immunol. 1992;90:330–335.[Medline] [Order article via Infotrieve]

6. Kodama M, Matsumoto Y, Fujiwara M. In vivo lymphocyte-mediated myocardial injuries demonstrated by adoptive transfer of experimental autoimmune myocarditis. Circulation. 1992;85:1918–1926.[Abstract/Free Full Text]

7. Smith SC, Allen PM. Myosin-induced acute myocarditis is a T cell-mediated disease. J Immunol. 1991;147:2141–2147.[Abstract]

8. Hanawa H, Kodama M, Inomata T, Izumi T, Shibata A, Tuchida M, Matsumoto Y, Abo T. Anti-{alpha}ß T cell receptor antibody prevents the progression of experimental autoimmune myocarditis. Clin Exp Immunol. 1994;96:470–475.[Medline] [Order article via Infotrieve]

9. Davis MM, Bjorkman PJ. T-cell antigen receptor genes and T-cell recognition. Nature. 1988;334:395–402.[Medline] [Order article via Infotrieve]

10. Fields BA, Ober B, Malchiodi EL, Lebedeva MI, Braden BC, Ysern X, Kim JK, Shao X, Ward ES, Mariuzza RA. Crystal structure of the V {alpha} domain of a T cell antigen receptor. Science. 1995;270:1821–1824.[Abstract/Free Full Text]

11. Hanawa H, Inomata T, Sekikawa H, Abo T, Kodama M, Izumi T, Shibata A. Analysis of heart-infiltrating T-cell clonotypes in experimental autoimmune myocarditis in rats. Circ Res. 1996;78:118–125.[Abstract/Free Full Text]

12. Okura Y, Yamamoto T, Goto S, Inomata T, Hirono S, Hanawa H, Feng L, Wilson C, Kihara I, Izumi T, Shibata A, Aizawa Y, Seki S, Abo T. Characterization of cytokine and iNOS mRNA expression in situ during the course of experimental autoimmune myocarditis in rats. J Mol Cell Cardiol. 1997;29:491–502.[Medline] [Order article via Infotrieve]

13. Hirono S, Islam O, Nakazawa M, Yoshida Y, Kodama M, Shibata A, Izumi T, Imai S. Expression of inducible nitric oxide synthase in rat experimental autoimmune myocarditis with special reference to changes in cardiac hemodynamics. Circ Res. 1997;80:11–20.[Abstract/Free Full Text]

14. Liao L, Sindhwani R, Leinwand L, Diamond B, Factor S. Cardiac {alpha}-myosin heavy chains differ in their induction of myocarditis: identification of pathogenic epitopes. J Clin Invest. 1993;92:2877–2882.

15. Pummerer CL, Luze K, Grassl G, Bachmaier K, Offner F, Burrell SK, Lenz DM, Zamborelli TJ, Penninger JM, Neu N. Identification of cardiac myosin peptides capable of inducing autoimmune myocarditis in BALB/c mice. J Clin Invest. 1996;97:2057–2062.[Medline] [Order article via Infotrieve]

16. Donermeyer DL, Beisel KW, Allen PM, Smith SC. Myocarditis-inducing epitope of myosin binds constitutively and stably to I-Ak on antigen-presenting cells in the heart. J Exp Med. 1995;182:1291–1300.[Abstract/Free Full Text]

17. Inomata T, Hanawa H, Miyanishi T, Yajima E, Nakayama S, Maita T, Kodama M, Izumi T, Shibata A, Abo T. Localization of porcine cardiac myosin epitopes that induce experimental autoimmune myocarditis. Circ Res. 1995;76:726–733.

18. Wegmann KW, Zhao W, Griffin AC, Hickey WF. Identification of myocarditogenic peptides derived from cardiac myosin capable of inducing experimental allergic myocarditis in the Lewis rat: the utility of a class II binding motif in selecting self-reactive peptides. J Immunol. 1994;153:892–900.[Abstract]

19. Gold DP, Vainiene M, Celnik B, Wiley S, Gibbs C, Hashim GA, Vandenbark AA, Offner H. Characterization of the immune response to a secondary encephalitogenic epitope of basic protein in Lewis rats, II: biased T cell receptor V ß expression predominates in spinal cord infiltrating T cells. J Immunol. 1992;148:1712–1717.[Abstract]

20. Hoshino S, Kimura A, Fukuda Y, Dohi K, Sasazuki T. Polymerase chain reaction–single-strand conformation polymorphism analysis of polymorphism in DPA1 and DPB1 genes: a simple, economical, and rapid method for histocompatibility testing. Hum Immunol. 1992;33:98–107.[Medline] [Order article via Infotrieve]

21. Offner H, Buenafe AC, Vainiene M, Celnik B, Weinberg AD, Gold DP, Hashim G, Vandenbark AA. Where, when, and how to detect biased expression of disease-relevant Vß genes in rats with experimental autoimmune encephalomyelitis. J Immunol. 1993;151:506–517.[Abstract]

22. Tsuchida M, Matsumoto Y, Hirahara H, Hanawa H, Tomiyama K, Abo T. Preferential distribution of Vß8.2-positive T cells in the central nervous system of rats with myelin basic protein-induced autoimmune encephalomyelitis. Eur J Immunol. 1993;23:2399–2406.[Medline] [Order article via Infotrieve]

23. Yamamoto K, Sakoda H, Nakajima T, Kato T, Okubo M, Dohi M, Mizushima Y, Ito K, Nishioka K. Accumulation of multiple T cell clonotypes in the synovial lesions of patients with rheumatoid arthritis revealed by a novel clonality analysis. Int Immunol. 1992;4:1219–1223.[Abstract/Free Full Text]

24. Stern LJ, Brown JH, Jardetzky TS, Gorga JC, Urban RG, Strominger JL, Wiley DC. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature. 1994;368:215–221.[Medline] [Order article via Infotrieve]

25. Yamamura T, Kondo T, Sakanaka S, Kozovska M, Geng TC, Takahashi K, Tabira T. Analysis of T cell antigen receptors of myelin basic protein specific T cells in SJL/J mice demonstrates an alpha chain CDR3 motif associated with encephalitogenic T cells. Int Immunol. 1994;6:947–954.[Abstract/Free Full Text]

26. Udaka K, Wiesmuller KH, Kienle S, Jung G, Walden P. Decrypting the structure of major histocompatibility complex class I-restricted cytotoxic T lymphocyte epitopes with complex peptide libraries. J Exp Med. 1995;181:2097–2108.[Abstract/Free Full Text]

27. Burns FR, Li XB, Shen N, Offner H, Chou YK, Vandenbark AA, Heber-Katz E. Both rat and mouse T cell receptors specific for the encephalitogenic determinant of myelin basic protein use similar V {alpha} and V ß chain genes even though the major histocompatibility complex and encephalitogenic determinants being recognized are different. J Exp Med. 1989;169:27–39.[Abstract/Free Full Text]

28. Deleted in proof.

29. Zaller DM, Osman G, Kanagawa O, Hood L. Prevention and treatment of murine experimental allergic encephalomyelitis with T cell receptor V ß-specific antibodies. J Exp Med. 1990;171:1943–1955.[Abstract/Free Full Text]

30. Oksenberg JR, Panzara MA, Begovich AB, Mitchell D, Erlich HA, Murray RS, Shimonkevitz R, Sherritt M, Rothbard J, Bernard CC, et al. Selection for T-cell receptor V ß-D beta-J ß gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis. Nature. 1993;362:68–70.[Medline] [Order article via Infotrieve]

31. Gold DP, Offner H, Sun D, Wiley S, Vandenbark AA, Wilson DB. Analysis of T cell receptor ß chains in Lewis rats with experimental allergic encephalomyelitis: conserved complementarity determining region 3. J Exp Med. 1991;174:1467–1476.[Abstract/Free Full Text]

32. Weiss LM, Movahed LA, Billingham ME, Cleary ML. Detection of Coxsackievirus B3 RNA in myocardial tissues by the polymerase chain reaction. Am J Pathol. 1991;138:497–503.[Abstract]

33. Herskowitz A, Wu TC, Willoughby SB, Vlahov D, Ansari AA, Beschorner WE, Baughman KL. Myocarditis and cardiotropic viral infection associated with severe left ventricular dysfunction in late-stage infection with human immunodeficiency virus. J Am Coll Cardiol. 1994;24:1025–1032.[Abstract]

34. Matsumori A, Matoba Y, Sasayama S. Dilated cardiomyopathy associated with hepatitis C virus infection. Circulation. 1995;92:2519–2525.[Abstract/Free Full Text]

35. Rose NR, Herskowitz A, Neumann DA. Autoimmunity in myocarditis: models and mechanisms. Clin Immunol Immunopathol. 1993;68:95–99.

36. Badorff C, Noutsias M, Kuhl U, Schultheiss HP. Cell-mediated cytotoxicity in hearts with dilated cardiomyopathy: correlation with interstitial fibrosis and foci of activated T lymphocytes. J Am Coll Cardiol. 1997;29:429–434.[Abstract]

37. Schwimmbeck PL, Badorff C, Rohn G, Schulze K, Schultheiss HP. The role of sensitized T-cells in myocarditis and dilated cardiomyopathy. Int J Cardiol. 1996;54:117–125.[Medline] [Order article via Infotrieve]

38. Seko Y, Yagita H, Okumura K, Yazaki Y. T-cell receptor V ß gene expression in infiltrating cells in murine hearts with acute myocarditis caused by coxsackievirus B3. Circulation. 1994;89:2170–2175.[Abstract/Free Full Text]

39. Seko Y, Ishiyama S, Nishikawa T, Kasajima T, Hiroe M, Kagawa N, Osada K, Suzuki S, Yagita H, Okumura K, Yazaki Y. Restricted usage of T cell receptor V {alpha}-V ß genes in infiltrating cells in the hearts of patients with acute myocarditis and dilated cardiomyopathy. J Clin Invest. 1995;96:1035–1041.

40. Seko Y, Yoshifumi E, Yagita H, Okumura K, Yazaki Y. Restricted usage of T-cell receptor V {alpha} genes in infiltrating cells in murine hearts with acute myocarditis caused by coxsackie virus B3. J Pathol. 1996;178:330–334.[Medline] [Order article via Infotrieve]

41. Neu N, Pummerer C, Rieker T, Berger P. T cells in cardiac myosin-induced myocarditis. Clin Immunol Immunopathol. 1993;68:107–110.[Medline] [Order article via Infotrieve]

42. Maisch B, Bauer E, Cirsi M, Kochsiek K. Cytolytic cross-reactive antibodies directed against the cardiac membrane and viral proteins in coxsackievirus B3 and B4 myocarditis: characterization and pathogenetic relevance. Circulation. 1993;87(suppl IV):IV-49–IV-65.

43. Schulze K, Becker BF, Schauer R, Schultheiss HP. Antibodies to ADP-ATP carrier—an autoantigen in myocarditis and dilated cardiomyopathy—impair cardiac function. Circulation. 1990;81:959–969.[Abstract/Free Full Text]

44. Neumann DA, Lane JR, LaFond-Walker A, Allen GS, Wulff SM, Herskowitz A, Rose NR. Heart-specific autoantibodies can be eluted from the hearts of Coxsackievirus B3-infected mice. Clin Exp Immunol. 1991;86:405–412.[Medline] [Order article via Infotrieve]

45. Huber SA, Cunningham MW. Streptococcal M protein peptide with similarity to myosin induces CD4+ T cell-dependent myocarditis in MRL/++ mice and induces partial tolerance against coxsackieviral myocarditis. J Immunol. 1996;156:3528–3534.[Abstract]

46. Cunningham MW, Antone SM, Gulizia JM, McManus BM, Fischetti VA, Gauntt CJ. Cytotoxic and viral neutralizing antibodies crossreact with streptococcal M protein, enteroviruses, and human cardiac myosin. Proc Natl Acad Sci U S A. 1992;89:1320–1324.[Abstract/Free Full Text]

47. Carlquist JF, Ward RH, Husebye D, Feolo M, Anderson JL. Major histocompatibility complex class II gene frequencies by serologic and deoxyribonucleic acid genomic typing in idiopathic dilated cardiomyopathy. Am J Cardiol. 1994;74:918–920.[Medline] [Order article via Infotrieve]

48. Carlquist JF, Menlove RL, Murray MB, O'Connell JB, Anderson JL. HLA class II (DR and DQ) antigen associations in idiopathic dilated cardiomyopathy: validation study and meta-analysis of published HLA association studies. Circulation. 1991;83:515–522.[Abstract/Free Full Text]

49. Hammer J, Valsasnini P, Tolba K, Bolin D, Higelin J, Takacs B, Sinigaglia F. Promiscuous and allele-specific anchors in HLA-DR-binding peptides. Cell. 1993;74:197–203.[Medline] [Order article via Infotrieve]

50. Hammer J, Gallazzi F, Bono E, Karr RW, Guenot J, Valsasnini P, Nagy ZA, Sinigaglia F. Peptide binding specificity of HLA-DR4 molecules: correlation with rheumatoid arthritis association. J Exp Med. 1995;181:1847–1855.[Abstract/Free Full Text]

51. Smith LR, Kono DH, Theofilopoulos AN. Complexity and sequence identification of 24 rat V beta genes. J Immunol. 1991;147:375–379.[Abstract]





This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hanawa, H.
Right arrow Articles by Aizawa, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hanawa, H.
Right arrow Articles by Aizawa, Y.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Autoimmune Diseases
*Cardiomyopathy